Viewing Study NCT04812002


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2025-12-26 @ 3:01 AM
Study NCT ID: NCT04812002
Status: RECRUITING
Last Update Posted: 2022-06-03
First Post: 2021-03-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy
Sponsor: Women's Hospital School Of Medicine Zhejiang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module